cbdMD, Inc. (YCBD) |
| 0.5 0.003 (0.58%) 08-28 16:00 |
| Open: | 0.5139 |
| High: | 0.5139 |
| Low: | 0.48 |
| Volume: | 153,727 |
| Market Cap: | 5(M) |
| PE Ratio: | -1.23 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 0.62 |
| Resistance 1: | 0.56 |
| Pivot price: | 0.52 |
| Support 1: | 0.47 |
| Support 2: | 0.39 |
| 52w High: | 2.56 |
| 52w Low: | 0.465 |
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Sun, 23 Aug 2026
YCBD | cbdMD, Inc. Common Stock Financials - Revenue Breakdown - Quiver Quantitative
Sun, 23 Aug 2026
cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest Reading - Earnings Quality Analysis - vinanet.vn
Thu, 13 Aug 2026
Oasis beverage distribution more than quadruples Texas store access - Stock Titan
Mon, 10 Aug 2026
cbdMD schedules 4:20 p.m. call to discuss June 30 results - Stock Titan
Mon, 10 Aug 2026
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results - Yahoo Finance
Mon, 03 Aug 2026
cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products - PR Newswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |